Quest Pharmatech Inc (TSE:QPT)
TSXV:QPT
Canadian Market
Holding TSE:QPT?
Track your performance easily

Quest Pharmatech (QPT) Income Statement

4 Followers

Quest Pharmatech Income Statement

Last quarter (Q2 2025), Quest Pharmatech's total revenue was C$―, a decrease of -100.00% from the same quarter last year. In Q2, Quest Pharmatech's net income was C$719.56K. See Quest Pharmatech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jan 24Jan 23Jan 22Jan 21Jan 20
Total Revenue
-----C$ 0.00
Cost of Revenue
------
Gross Profit
------
Operating Expense
C$ 1.34MC$ 1.83MC$ 834.22K-C$ 1.07MC$ 13.63M
Operating Income
C$ -1.34MC$ -1.83MC$ -834.22K-C$ -1.07MC$ -13.63M
Net Non Operating Interest Income Expense
C$ -23.19KC$ -20.68KC$ -21.00K-C$ 5.94KC$ 33.19K
Other Income Expense
C$ -13.19MC$ 1.16MC$ 6.48M-C$ 191.14MC$ 346.95K
Pretax Income
C$ 11.83MC$ -3.02MC$ -7.33M-C$ 190.06MC$ -13.25M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
C$ -683.42K-C$ -3.10M-C$ 164.17M-
Net Income Common Stockholders
C$ 11.83MC$ -3.02MC$ -7.33M-C$ 190.06MC$ -6.18M
Basic EPS
C$ 0.07C$ -0.02C$ -0.04-C$ 1.13C$ -0.04
Diluted EPS
C$ 0.07C$ -0.02C$ -0.04-C$ 1.11C$ -0.04
Basic Average Shares
C$ 676.52MC$ 169.13MC$ 168.40M-C$ 167.79MC$ 167.40M
Diluted Average Shares
C$ 676.52MC$ 169.13MC$ 168.40M-C$ 167.79MC$ 167.40M
Dividend Per Share
-----C$ 0.00
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
C$ 1.16M-C$ 834.22K-C$ -1.07MC$ 13.63M
Net Income From Continuing And Discontinued Operation
C$ 11.83MC$ -3.02MC$ -7.33M-C$ 190.06MC$ -6.18M
Normalized Income
C$ 8.66MC$ -2.22MC$ -5.39MC$ -85.04MC$ 11.38MC$ -6.54M
Interest Expense
-----C$ 13.74K
EBIT
C$ 11.85MC$ -3.00MC$ -7.31MC$ -85.03MC$ 190.07MC$ -13.24M
EBITDA
C$ 11.85MC$ -2.99MC$ -7.30MC$ -84.99MC$ 190.11MC$ -13.20M
Currency in CAD

Quest Pharmatech Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis